이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Monash IVF Group 관리

관리 기준 확인 3/4

Monash IVF Group's CEO는 Michael Knaap, Oct2018 에 임명되었습니다 의 임기는 5.67 년입니다. 총 연간 보상은 A$ 1.04M, 54.6% 로 구성됩니다. 54.6% 급여 및 45.4% 보너스(회사 주식 및 옵션 포함). 는 A$ 971.87K 가치에 해당하는 회사 주식의 0.19% 직접 소유합니다. 971.87K. 경영진과 이사회의 평균 재임 기간은 각각 4.9 년과 8.8 년입니다.

주요 정보

Michael Knaap

최고 경영자

AU$1.2m

총 보상

CEO 급여 비율	49.8%
CEO 임기	6yrs
CEO 소유권	0.2%
경영진 평균 재임 기간	5.3yrs
이사회 평균 재임 기간	9.2yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Michael Knaap 의 보수는 Monash IVF Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	AU$1m	AU$601k	-AU$7m
Mar 31 2024	n/a	n/a	AU$9m
Dec 31 2023	n/a	n/a	AU$24m
Sep 30 2023	n/a	n/a	AU$23m
Jun 30 2023	AU$1m	AU$567k	AU$22m
Mar 31 2023	n/a	n/a	AU$19m
Dec 31 2022	n/a	n/a	AU$17m
Sep 30 2022	n/a	n/a	AU$18m
Jun 30 2022	AU$794k	AU$552k	AU$18m
Mar 31 2022	n/a	n/a	AU$21m
Dec 31 2021	n/a	n/a	AU$23m
Sep 30 2021	n/a	n/a	AU$24m
Jun 30 2021	AU$908k	AU$501k	AU$25m
Mar 31 2021	n/a	n/a	AU$22m
Dec 31 2020	n/a	n/a	AU$18m
Sep 30 2020	n/a	n/a	AU$15m
Jun 30 2020	AU$561k	AU$479k	AU$12m
Mar 31 2020	n/a	n/a	AU$15m
Dec 31 2019	n/a	n/a	AU$18m
Sep 30 2019	n/a	n/a	AU$19m
Jun 30 2019	AU$520k	AU$402k	AU$20m
Mar 31 2019	n/a	n/a	AU$19m
Dec 31 2018	n/a	n/a	AU$19m
Sep 30 2018	n/a	n/a	AU$20m
Jun 30 2018	AU$424k	AU$350k	AU$21m

보상 대 시장: Michael 의 총 보상 ($USD 692.82K )은 Australian 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 783.32K ).

보상과 수익: 회사가 수익성이 없는 동안 Michael 의 보상이 증가했습니다.

CEO

Michael Knaap

6yrs

테뉴어

AU$1,207,516

보상

Mr. Michael D. Knaap serves as Chief Executive Officer, Managing Director and Executive Director of Monash IVF Group Limited since April 15, 2019. Mr. Knaap served as an Interim Chief Executive Officer of...

리더십 팀

이름	위치	테뉴어	보상	소유권
Michael Knaap	CEO, MD & Executive Director	6yrs	AU$1.21m	0.23% A$ 1.1m
Malik Jainudeen	Group CFO & Company Secretary	5.5yrs	AU$583.85k	0.0049% A$ 23.6k
Hamish Hamilton	Chief Operating Officer	4.6yrs	AU$608.35k	0.041% A$ 197.6k
Richard Henshaw	Executive Director	10.5yrs	AU$393.90k	0.35% A$ 1.7m
Deirdre Zander-Fox	Chief Scientific Officer	no data	데이터 없음	데이터 없음
Thierry Panthier	Chief Information Officer	2.8yrs	데이터 없음	데이터 없음
Fiona Allen	Chief Marketing Officer	5.3yrs	데이터 없음	데이터 없음
Peggy North	Chief People & Culture Officer	no data	데이터 없음	데이터 없음
Tedd Fuell	Chief Governance & Risk Officer	no data	데이터 없음	데이터 없음
Johannes Lagerwij	Managing Director of Asia	1.8yrs	데이터 없음	데이터 없음

5.3yrs

평균 재임 기간

경험이 풍부한 관리: MVF 의 관리팀은 노련하고 경험 (평균 재직 기간 5 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Michael Knaap	CEO, MD & Executive Director	5.5yrs	AU$1.21m	0.23% A$ 1.1m
Richard Henshaw	Executive Director	10.5yrs	AU$393.90k	0.35% A$ 1.7m
Neil Broekhuizen	Independent Non-Executive Director	10.3yrs	AU$107.65k	0.090% A$ 428.8k
Josef Czyzewski	Independent Non-Executive Director	10.3yrs	AU$126.38k	0.059% A$ 283.4k
Richard Davis	Independent Non-Executive Chairman	10.3yrs	AU$183.69k	0.047% A$ 223.0k
Zita Peach	Independent Non-Executive Director	8yrs	AU$117.03k	0.024% A$ 113.7k
Catherine West	Independent Non-Executive Director	4.1yrs	AU$107.65k	0.0095% A$ 45.4k
Catherine Aston	Independent Non-Executive Director	less than a year	AU$35.88k	0.020% A$ 94.3k

9.2yrs

평균 재임 기간

64.5yo

평균 연령

경험이 풍부한 이사회: MVF 의 이사회는 경험(평균 재직 기간 8.8 년)으로 간주됩니다.

Monash IVF Group 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

Insufficient new directors

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Recent updates

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought AU$93k worth of stock

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought AU$192k worth of stock

New 90-day low: AU$0.70

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

New 90-day high: AU$0.72

New 90-day high: AU$0.65

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

이사회 구성원

평균 재임 기간

평균 연령